Effect of oxidized low-density lipoprotein on differential gene expression in primary human endothelial cells

Antioxidants and Redox Signaling

Volumn 5, Issue 2, 2003, Pages 237-247

  Virgili, Fabio ^a   Ambra, Roberto ^a   Muratori, Flaminia ^a   Natella, Fausta ^a   Majewicz, Jonathan ^b   Minihane, Anne Marie ^b   Rimbach, Gerald ^b  

^a ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CELL RECEPTOR; COMPLEMENTARY DNA; CONNECTIVE TISSUE GROWTH FACTOR; ENZYME; FARNESYL TRANS TRANSFERASE; FIBRONECTIN; GELATINASE B; GROWTH FACTOR; OXIDIZED LOW DENSITY LIPOPROTEIN; PADGEM PROTEIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; SCLEROPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 2;

AMPLICON; ARTICLE; ATHEROGENESIS; CHOLESTEROL METABOLISM; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; GENE IDENTIFICATION; GENE TECHNOLOGY; GENETIC DIFFERENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN;

EID: 0037395492     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308603764816596     Document Type: Article

References (50)

1. Berliner JA and Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 20: 707-727, 1996.
2. Casey PJ. Protein lipidation in cell signaling. Science 268: 221-225, 1995.
3. Charvat S, Duchesne M, Parvaz P, Chignol MC, Schmitt D, and Serres M. The up-regulation of vascular endothelial growth factor in mutated Ha-ras HaCaT cell lines is reduced by a farnesyl transferase inhibitor. Anticancer Res 19:557-561, 1999.
4. Chen BP, Li YS, Zhao Y, Chen KD, Li S, Lao J, Yuan S, Shyy JY, and Chien S. DNA microarray analysis of gene expression in endothelial cells in response to 24-h shear stress. Physiol Genomics 7: 55-63, 2001.
5. Claise C, Edeas M, Chaouchi N, Chalas J, Capel L, Kalimouttou S, Vazquez A, and Lindenbaum A. Oxidized-LDL induce apoptosis in HUVEC but not in the endothelial cell line EA.hy 926. Atherosclerosis 14: 95-104, 1999.
6. Coombes BK and Mahony JB. cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection. Infect Immun 69: 1420-1427, 2001.
7. Dimmeler S, Haendeler J, Galle J, and Zeiher AM. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the "response to injury" hypothesis. Circulation 95: 1760-1763, 1997.
8. Fan WH, and Karnovsky MJ. Increased MMP-2 expression in connective tissue growth factor overexpression vascular smooth muscle cells. J Biol Chem 277: 9800-9805, 2002.
9. Fischer A, Pallauf J, Gohil K, Weber SU, Packer L, and Rimbach G. Effect of selenium and vitamin E deficiency on differential gene expression in rat liver. Biochem Biophys Res Commun 285: 470-475, 2001.
10. Fischer A, Pallauf J, and Rimbach G. Selenium- and vitamin E-dependent gene expression in rats: analysis of differentially expressed mRNAs. Methods Enzymol 347: 267-276, 2002.
11. Gerrity RG. The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 103: 181-190, 1981.
12. Goalstone ML, Natarajan R, Standley PR, Walsh MF, Leitner JW, Carel K, Scott S, Nadler J, Sowers JR, and Draznin B. Insulin potentiates platelet-derived growth factor action in vascular smooth muscle cells. Endocrinology 139: 4067-4072, 1998.
13. Grewal T, Heerent J, Mewawala D, Schnitgerhanst T, Wendt D, Salomon G, Enrich C, Beisiegel U, and Jackle S. Annexin VI stimulates endocytosis and is involved in the trafficking of LDL to prelysosomal compartment. J Biol Chem 275: 33806-33813, 2000.
14. Havel JR, Eder HA, and Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353, 1955.
15. Hellmann GM, Fields WR, and Doolittle DJ. Gene expression profiling of cultured human bronchial epithelial and lung carcinoma cells. Toxicol Sci 61: 154-163, 2001.
16. Ishizuka T, Sawada S, Sugama K, and Kurita A. Thromboxane A2 (TXA2) receptor blockade suppresses monocyte chemoattractant protein-1 (MCP-1) expression by stimulated vascular endothelial cells. Clin Exp Immunol 120: 71-78, 2000.
17. Jaffe EA, Nachman RL, Becker CG, and Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 52: 2745-2756, 1973.
18. Kuller LH and Tracy RP. The role of inflammation in cardiovascular disease. Arterioscler Thromb Vasc Biol 20: 901, 2000.
19. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
20. McCormick SM, Eskin SG, McIntire LV, Teng CL, Lu CM, Russell CG, and Chittur KK. DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells. Proc Natl Acad Sci U S A 98: 8955-8960, 2001.
21. Morawietz H, Duerrschmidt N, Niemann B, Galle J, Sawamura T, and Holtz J. Induction of the oxLDL receptor LOX-1 by endothelin-1 in human endothelial cells. Biochem Biophys Res Commun 284: 961-965, 2001.
22. Morla AO and Mogford JE. Control of smooth muscle cell proliferation and phenotype by integrin signaling through focal adhesion kinase. Biochem Biophys Res Commun 272: 298-302, 2000.
23. Murakami T, Mataki C, Nagao C, Umetani M, Wada Y, Ishii M, Tsutsumi S, Kohro T, Saiura A, Aburatani H, Hamakubo T, and Kodama T. The gene expression profile of human umbilical vein endothelial cells stimulated by tumor necrosis factor alpha using DNA microarray analysis. J Atherioscler Thromb 7: 39-44, 2000.
24. Nagase T, Kawata S, Nakajima H, Tamura S, Yamasaki E, Fukui K, Yamamoto K, Miyagawa J, Matsumura I, Matsuda Y, and Matsuzawa Y. Effect of farnesyltransferase overexpression on cell growth and transformation. Int J Cancer 80:126-133, 1999.
25. Nicholson AC, Han J, Febbraio M, Silversterin RL, and Hajjar DP. Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis. Ann N Y Acad Sci 947: 224-228, 2001.
26. Pan J and McEver RP. Characterization of the promoter for the human P-selectin gene. J Biol Chem 268: 22600-22608, 1993.
27. Parasassi T, Bittolo-Bon G, Brunelli R, Cazzolato G, Krasnowska EK, Mei G, Sevanian A, and Ursini F. Loss of apoB-100 secondary structure and conformation in hydroperoxide rich, electronegative LDL(-). Free Radic Biol Med 31: 82-89, 2001.
28. Parthasarathy S, Santanam N, Ramachandran S, and Meilhac O. Oxidants and antioxidants in atherogenesis. An appraisal. J Lipid Res 40: 2143-2157, 1999.
29. Peschen M, Grenz H, Brand-Saberi B, Bunaes M, Simon JC, Schopf E, and Vanscheidt W. Increased expression of platelet-derived growth factor receptor alpha and beta and vascular endothelial growth factor in the skin of patients with chronic venous insufficiency. Arch Dermatol Res 290: 291-297, 1998.
30. Ravandi A, Kuksis A, and Shaikh NA. Glycated phosphatidylethanolamine promotes macrophage uptake of LDL and accumulation of cholesteryl esters and triacylglycerols. J Biol Chem 274: 16494-16500, 1999.
31. Rimbach G, Valacchi G, Canali R, and Virgili F. Macrophages stimulated with IFN-gamma activate NF-kappa B and induce MCP-1 gene expression in primary human endothelial cells. Mol Cell Biol Res Commun 3: 238-242, 2000.
32. Rimbach G, Saliou C, Canali R, and Virgili F. Interaction between cultured endothelial cells and macrophages: in vitro model for studying flavonoids in redox-dependent gene expression. Methods Enzymol 335: 387-397, 2001.
33. Sakakura Y, Shimano H, Sone H, Takahashi A, Inoue N, Toyoshima H, Suzuki S, Yamada N, and Inoue K. Sterol regulatory element-binding proteins induce an entire pathway of cholesterol synthesis. Biochem Biophys Res Commun 286: 176-183, 2001.
34. Schatteman GC, Morrison-Graham K, van Koppen A, Weston JA, and Bowen-Pope DF. Regulation and role of PDGF receptor alpha-subunit expression during embryogenesis. Development 115: 123-131, 1992.
35. Schmidt AM, Yan SD, Yan SF, and Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108: 949-955, 2001.
36. Sevanian A. Phospholipase and lipid peroxidation. In: Cellular Antioxidant Defence Mechanism, edited by Chow CK. Boca Raton, FL: CRC Press, 1988, pp. 77-95.
37. Sevanian A, Asatryan L, and Ziouzenkova O. Low density lipoprotein (LDL) modification: basic concepts and relationship to atherosclerosis. Blood Purif 17: 66-78, 1999.
38. Steinbrecher UP. Receptors for oxidized low density lipoprotein. Biochim Biophys Acta 1436: 279-298, 1999.
39. Takei A, Huang Y, and Lopes-Virella MF. Expression of adhesion molecules by human endothelial cells exposed to oxidized low density lipoprotein. Influences of degree of oxidation and location of oxidized LDL. Atherosclerosis 154: 79-86, 2001.
40. Tanimoto H, Mehta KD, Parmley TH, Shigemasa K, Parham GP, Clarke J, and O'Brien TJ. Expression of the farnesyltransferase beta-subunit gene in human ovarian carcinoma: correlation to K-ras mutation. Gynecol Oncol 66:308-312, 1997.
41. Ursini F, Davies KJ, Maiorino M, Parasassi T, and Sevanian A. Atherosclerosis: another protein misfolding disease? Trends Mol Med 8: 370-374, 2002.
42. Van Lente F. Markers of inflammation as predictors in cardiovascular disease. Clin Chim Acta 293: 31-52, 2000.
43. Wautier JL and Guillausseau PJ. Advanced glycation end products, their receptors and diabetic angiopathy. Diabetes Metab 27: 535-542, 2001.
44. Weigel G, Griesmacher A, Toma CD, Baecker C, Heinzl H, and Mueller MM. Endothelial eicosanoid metabolism and signal transduction during exposure to oxygen radicals injury. Thromb Res 87: 363-375, 1997.
45. Xu XP, Meisel SR, Ong JM, Kaul S, Cercek B, Rajavashisth TB, Sharifi B, and Shah PK. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation 99: 993-998, 1999.
46. Yuan Y, Verna LK, Wang NP, Liao HL, Ma KS, Wang Y, Zhu Y, and Stemerman MB. Cholesterol enrichment upregulates intercellular adhesion molecule-1 in human vascular endothelial cells. Biochim Biophys Acta 1534: 139-148, 2001.
47. Yue H, Eastman PS, Wang BB, Minor J, Doctolero MH, Nuttall RL, Stack R, Becker JW, Montgomery JR, Vainer M, and Johnston R. An evaluation of the performance of cDNA microarrays for detecting changes in global mRNA expression. Nucleic Acids Res 29: E41-41, 2001.
48. Zhang FL and Casey RJ. Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem 65: 241-269, 1996.
49. Zhao B, Bowden RA, Stavchansky SA, and Bowman PD. Human endothelial cell response to gram-negative lipopolysaccharide assessed with cDNA microarrays. Am J Physiol Cell Physiol 281: C1587-C1595, 2001.
50. Zhao SP and Xu DY. Oxidized lipoprotein(a) enhanced the expression of P-selectin in cultured human umbilical vein endothelial cells. Thromb Res 100: 501-510, 2000.